PTC Therapeutics (United States)
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control mechanisms in orphan diseases. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for PTC Therapeutics (United States), United States, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
49%
Total
Publications
502
Total Open
Publications
245
Total
Citations
15K
Open Access
Percentage
49%
Total
Publications
502
Total Open
Publications
245
Total
Citations
15K
Breakdown
Publisher Open
14%
Both
27%
Other Platform Open
7%
Closed
52%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 40%
82
Hybrid 28%
57
No Guarantees 32%
65
Other Platform Open
Domain 80%
139
Institution 45%
78
Other Internet 8%
14
Preprint 7%
13
Public 3%
6
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 142 |
doaj.org OAI-PMH Repository | Institution | 46 |
DOI | Other Internet | 13 |
bioRxiv | Preprint | 10 |
California Digital Library | Institution | 9 |
Figshare | Public | 6 |
University of Groningen | Institution | 4 |
The University of Melbourne | Institution | 4 |
Washington University in St. Louis | Institution | 3 |
University of Milan | Institution | 3 |